Pharmaceutical Supply of Norgestrel and Ethinyl Estradiol Tablets

The contract involves the manufacture and supply of FDA-approved generic oral contraceptive tablets containing norgestrel and ethinyl estradiol, specifically for delivery under Department of Defense requirements. The product must fully comply with all regulatory standards set by the Food and Drug Administration as well as the Department of Defense’s strict packaging, labeling, and identification protocols to ensure military readiness and distribution consistency. The agreement is structured as a subcontract under the Defense Logistics Agency, with the NAICS code 325412 indicating pharmaceutical preparation manufacturing as the primary industry classification. The work is intended to meet the healthcare needs of DOD beneficiaries through assured, reliable supply chains compliant with federal procurement and quality control guidelines. The contract was posted on August 9, 2026, and is trackable via the DIBBS system under the referenced contract identifiers.